Moody's CEO sells 1,467 shares at $501.89
MOODYS CORP (MCO) reported that President and CEO Robert Fauber exercised stock options and sold common shares on September 1, 2026 under a pre-arranged trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MOODYS CORP (MCO) reported that President and CEO Robert Fauber exercised stock options and sold common shares on September 1, 2026 under a pre-arranged trading plan. He exercised options for 592 shares at $113.34 and 575 shares at $167.50 per share, receiving 1,167 common shares, and then sold a total of 1,467 common shares at $501.89 per share, including 300 shares not tied to those option exercises. The filing also reports 22,325 common shares held indirectly in a trust following these transactions.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
7 txns
Insider
Fauber Robert
Role
President and CEO
Sold
1,467 shs ($736K)
Approx. gross sale proceeds
$736K
Approx. exercise cost
$163K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) F2, F3 | 592 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (right to buy) F2, F3 | 575 | $0.00 | $0.00 |
| Sale | Common Stock F1 | 300 | $501.89 | $151K |
| Exercise | Common Stock F2 | 592 | $113.34 | $67K |
| Exercise | Common Stock F2 | 575 | $167.50 | $96K |
| Sale | Common Stock F2 | 1,167 | $501.89 | $586K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 623 contracts (Direct);
Common Stock — 51,663.918 shares (Direct);
Common Stock — 22,325 shares (Indirect, Trust)
Footnotes (3)
- F1. Sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2025.
- F2. Exercise and sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2025.
- F3. One fourth of options vest each year beginning with the date indicated.
Key Figures
Options exercised at $113.34: 592 shares
Options exercised at $167.50: 575 shares
Common shares sold under 10b5-1 exercise-and-sale: 1,167 shares
+5 more
8 metrics
Options exercised at $113.34
592 shares
Employee stock options exercised into common stock on September 1, 2026 at $113.34 per share
Options exercised at $167.50
575 shares
Employee stock options exercised into common stock on September 1, 2026 at $167.50 per share
Common shares sold under 10b5-1 exercise-and-sale
1,167 shares
Common stock sold on September 1, 2026 at $501.89 per share related to option exercises
Additional common shares sold
300 shares
Common stock sold on September 1, 2026 at $501.89 per share under a Rule 10b5-1 plan
Total common shares sold
1,467 shares
Aggregate of both reported common stock sales on September 1, 2026
Sale price for common stock
$501.89 per share
Price for 1,467 common shares sold on September 1, 2026
Indirect common shares held in trust
22,325 shares
Indirect ownership in a trust following the reported transactions
Rule 10b5-1 plan adoption date
July 30, 2025
Date Mr. Fauber adopted the trading plan governing the reported sales and related exercises
Key Terms
Rule 10b5-1 plan, Employee Stock Option, vest
3 terms
Rule 10b5-1 plan regulatory
"Sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2025."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
vest financial
"One fourth of options vest each year beginning with the date indicated."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MCO’s CEO Robert Fauber report in this Form 4?
He exercised stock options for 1,167 common shares of MOODYS CORP and sold 1,467 common shares on September 1, 2026, including 300 shares not tied to those option exercises.
Were Robert Fauber’s MCO transactions made under a Rule 10b5-1 plan?
Yes. The filing states that the sale of 300 shares and the exercise and related sale of shares were made pursuant to a Rule 10b5-1 plan adopted on July 30, 2025.
What types of securities were involved in Robert Fauber’s MCO Form 4?
The Form 4 reports activity in Employee Stock Options (rights to buy common stock) that were exercised into common shares, and subsequent transactions in common stock itself, including both acquisitions from exercises and sales.
When do the MCO options reported for Robert Fauber expire?
The options exercised for 592 shares at $113.34 expire on February 23, 2027. The options exercised for 575 shares at $167.50 expire on February 16, 2028.
AI-generated analysis. How Rhea-AI works. Not financial advice.
